Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 22 points (0.1%) at 15,424 as of Tuesday, Sept. 24, 2013, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,875 issues advancing vs. 1,030 declining with 132 unchanged. The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.2%. Top gainers within the industry include Centene Corporation ( CNC), up 3.3%, and Humana ( HUM), up 1.0%. A company within the industry that fell today was Intuitive Surgical ( ISRG), up 1.0%. TheStreet would like to highlight 5 stocks pushing the industry higher today: 5. Hologic ( HOLX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Hologic is up $0.52 (2.6%) to $20.59 on heavy volume. Thus far, 2.9 million shares of Hologic exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $20.20-$20.59 after having opened the day at $20.33 as compared to the previous trading day's close of $20.07. Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. Hologic has a market cap of $5.5 billion and is part of the health care sector. Shares are up 0.7% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 6 rate it a hold. TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk. Get the full Hologic Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.